Many NHS partnerships with drug companies out of public sight: BMJ investigation
Drug companies spent over £7.5m on joint working in 2016-17, but 1 in 5 NHS trusts are keeping details secret. This goes against…
Author
ISCR welcomes new drugs and clinical trial rules, 2019
New rules well balanced, focused on patient rights, safety and well-being
Laurus Labs enters into strategic partnership agreement with Global Fund
Laurus Labs received a maiden TLD order and executed post the USFDA approval in February 2019
Lupin, YL Biologics receive nod to market rheumatoid arthritis drug in Japan
Biosimilar Etanercept is indicated to treat moderate to severe rheumatoid arthritis (RA) and juvenile idiopathic arthritis
Duke and US Government reach settlement on research misconduct case
Duke discovered the possible research misconduct in 2013 after the technician was fired for embezzling money from the university
Government notifies new rules for drugs and clinical trials
The new rules reduce the time for approving applications to 30 days for drugs manufactured in India and 90 days for those…
FDA rejects Sanofi-Lexicon add-on pill for type 1 diabetes
The setback comes as Sanofi works to revive declining sales from its diabetes division and faces increasing pressure from…
USFDA nod for generic version of Viagra tablet
The Mumbai-based company has received approval for its product in various strengths
Zydus Cadila gets USFDA nod for generic mental disorders drug
The drug, lurasidone hydrochloride tablets, will be manufactured at the group's manufacturing facility at SEZ, Ahmedabad
USFDA classifies Jubilant Life’s Nanjangud facility as ‘Official Action Indicated’
The USFDA also stated that the facility might be subject to a cGMP regulatory or enforcement action based on this inspection